title: N-(2-Chloro-pyrimidin-4-yl)-N,2-di-methyl-2H-indazol-6-amine.
abstract: In the title compound, C(13)H(12)ClN(5), which is a derivative of the anti-tumor agent pazopanib {systematic name: 5-[[4-[(2,3-di-methyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzolsulfonamide}, the indazole and pyrim-idine fragments form a dihedral angle of 62.63 (5)°. In the crystal, pairs of mol-ecules related by twofold rotational symmetry are linked into dimers through π-π inter-actions between the indazole ring systems [centroid-centroid distance = 3.720 (2) Å]. Weak inter-molecular C-H⋯N hydrogen bonds further assemble these dimers into columns propagated in [001].
authors: Hao-Fei
authors: HF
authors: Qi
authors: Bing-Ni
authors: BN
authors: Liu
authors: Mo
authors: M
authors: Liu
authors: Deng-Ke
authors: DK
authors: Liu
references: Curr Oncol Rep. 2007 Mar;9(2):115-9
references: 17288876
references: Acta Crystallogr A. 2008 Jan;64(Pt 1):112-22
references: 18156677
references: Curr Opin Investig Drugs. 2008 Dec;9(12):1324-35
references: 19037839
references: Expert Opin Pharmacother. 2009 Dec;10(18):3091-102
references: 19954277